Table 3.
Refinement statistics
| Model | EcGyr–Mu217–albicidin | EcGyr–Mu217–Albi-1-TG | EcGyr–Mu217–Albi-1-AA | EcGyr–Mu217–Albi-2 |
|---|---|---|---|---|
| Model resolution (Å) | 3.06 (3.47) | 3.25 (3.77) | 3.31 (0.143) | 3.24 (3.69) |
| FSC threshold | 0.143 (0.5) | 3.93 (0.5) | 0.143 (0.5) | |
| Map sharpening B factor (Å2) | 37.2 | 65.1 | 56.4 | 68.1 |
| Model composition | ||||
| Non-hydrogen atoms | 15,966 | 15,966 | 15,966 | 15,972 |
| Protein residues | 1,838 | 1,838 | 1,838 | 1,838 |
| Nucleotides | 64 | 64 | 64 | 64 |
| Ligands | 3 | 3 | 3 | 3 |
| B factors (Å2) | ||||
| Protein | 55.4 | 74.3 | 100.7 | 40.6 |
| Nucleotide | 73.9 | 96.8 | 118.2 | 63.1 |
| Ligands | 45.5 | 48.8 | 61.3 | 29.9 |
| R.M.S. deviations | ||||
| Bond lengths (Å) | 0.003 | 0.003 | 0.003 | 0.003 |
| Bond angles (°) | 0.577 | 0.568 | 0.601 | 0.559 |
| Validation | ||||
| MolProbity score | 1.31 | 1.28 | 1.33 | 1.24 |
| Clashscore | 1.59 | 1.79 | 1.79 | 1.56 |
| Ramachandran plot | ||||
| Favoured (%) | 93.97 | 95.07 | 94.13 | 95.18 |
| Allowed (%) | 6.03 | 4.93 | 5.87 | 4.82 |
| Disallowed (%) | 0.00 | 0.00 | 0.00 | 0.00 |